Monday, 25 Sep 2017

You are here

Dr. H. Ralph Schumacher (1933-2017)

Dr. H. Ralph Schumacher passed away from ALS in July 30, 2017. The current issues of The Rheumatologist  and the Journal of Clinical Rheumatology have beautiful tributes written by Dr. Simon Helfgott and past ACR president Dr. Joan VonFeldt on the passing of a giant in rheumatology. (Citation source https://buff.ly/2vkhWd8)  

You should read these pieces to capture the expanse of his medical pedigree, the range of influences and the impact Ralph had on many in his long and distguished career in rheumatology.

What I know about Ralph begins during my fellowship when I first listened and learned from him as he taught a room full of Rheumatology fellows on gout, and more specificially, on the use of the polarizing microscope in synovial fluid crystal analysis. He was detailed, method-driven and amazingly enthusiastic and demanding - all over these refractile diagnostic flecks of light!

Ralph was a teacher, academician, researcher and leader in our community.  He may be best known for his work in gout, crystals and clinical trials but for many he was their mentor in his role as Chief of Rheumatology at the Philadelphia Veterans Administration Medical Center.  For others he was the thoughtful, guiding hand as the innaugural and long-time Editor of the Journal of Clinical Rheumatology.

What I will remember most about Ralph was his committment to do the right thing, take no shortcuts, answer the tough questions with the right answer and either perservere, stay the path or get out of the way. He was pensive and determined and lived up to the task of being a leader amongst men.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

22 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses survey results on membranous nephritis and patient perceptions of steroids, nonadherence, celebrity arthritis and IgG4 treatment.

CDC: 40% of U.S Adults Claim to Have Arthritis

The CDC has reported its 2013 and 2014 prevalence statistics for arthritis and other chronic medical conditions affecting U.S. adults aged ≥18 years. Data is drawn from the ongoing Behavioral Risk Factor Surveillance System (BRFSS), a state-based, telephone survey of noninstitutionalized adults. Data herein is self-reported arthritis (OA, RA, Gout, FM) and is quantified by state and metropolitan areas.

15 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses metabolic syndrome in lupus, bisphosphonate holidays, vasculitis and vascular inflammation, vaccination, and the repeated wonders of Vitamin D.

Why Rheumatologists Should Do Better Vaccinating this Flu Season

It is well known that influenza infection is more common in patients with rheumatologic diseases. Blumentals et al. showed that patients with rheumatoid arthritis are at increased risk for influenza regardless of DMARD/biologic use and may have a 2.75-fold increased incidence of related complications (https://buff.ly/2gYNTSz).

8 September 2017: The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes trends in MTX use and outcomes, fibromyalgia as an inflammatory disorder, drugs that stop psoriasis pruritus, drugs that don't cause TB, cardiovascular risk, and what Rheums think of ACR/EULAR criteria.